{"schema_version":"secwatch.filing_event.v1","accession":"0001297184-23-000053","form_type":"8-K","ticker":"AMPH","cik":"0001297184","company_name":"Amphastar Pharmaceuticals, Inc.","filed_at":"2023-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.304892+00:00","generated_at":"2026-06-14T06:21:31.004289+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Amphastar shareholders elect three Class I directors, ratify auditor, approve say-on-pay at 2023 annual meeting","bullets":["Floyd F. Petersen, Jacob Liawatidewi, and William J. Peters elected as Class I directors to serve until 2026.","Ratification of Ernst & Young as independent auditor for FY2023: 42,097,266 for, 585,099 against.","Advisory vote on executive compensation approved: 37,281,658 for, 1,276,813 against, 4,029,572 broker non-votes.","All proposals passed; meeting held virtually on June 5, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001297184-23-000053","json":"https://secwatch.observer/filing/0001297184-23-000053.json","markdown":"https://secwatch.observer/filing/0001297184-23-000053.md","text":"https://secwatch.observer/filing/0001297184-23-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/0001297184-23-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/amph-20230605x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T06:21:31.004289+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e0ee17ecf39fe2a5eb0a78c2d295827752ec55b","claim":"Amphastar Pharmaceuticals, Inc. shareholders approved Election of three Class I directors to serve until the 2026 annual meeting at the 2023-06-05 meeting.","evidence_excerpt":"On June 5, 2023, the Company held its Annual Meeting virtually via a live webcast.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/0001297184-23-000053-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-05"}],"fact_type":"shareholder_vote"},{"claim_id":"d42ac2ff23eafe6019d8c635e81e53347a6dcf63","claim":"Amphastar Pharmaceuticals, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-05 meeting.","evidence_excerpt":"The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/0001297184-23-000053-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-05"}],"fact_type":"shareholder_vote"},{"claim_id":"d7f115a6a06160a848a020564c25c76868a52820","claim":"Amphastar Pharmaceuticals, Inc. shareholders approved Approve, on an advisory basis, the compensation of our named executive officers at the 2023-06-05 meeting.","evidence_excerpt":"To approve, on an advisory basis, the compensation of our named executive officers.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/0001297184-23-000053-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-05"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}